Right Ventricular Clot in Transit in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia Successfully Treated with Thrombolytics.
Journal
Case reports in critical care
ISSN: 2090-6420
Titre abrégé: Case Rep Crit Care
Pays: United States
ID NLM: 101598416
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
07
2021
accepted:
16
06
2022
entrez:
11
7
2022
pubmed:
12
7
2022
medline:
12
7
2022
Statut:
epublish
Résumé
Right heart thrombus or clot in transit is a rare venous thromboembolism (VTE) with high mortality. COVID-19 infection has been associated with increased risk of such events. We present the case of a 63-year-old man with no traditional VTE risk factors who was diagnosed with a clot in transit three weeks after diagnosis of COVID-19. Clot in transit is rare but can occur in COVID-19 patients even in the absence of traditional thromboembolism risk factors. Management includes systemic anticoagulation, systemic thrombolysis, and surgical embolectomy. Our patient was successfully treated with systemic thrombolysis.
Sections du résumé
Background
UNASSIGNED
Right heart thrombus or clot in transit is a rare venous thromboembolism (VTE) with high mortality. COVID-19 infection has been associated with increased risk of such events. We present the case of a 63-year-old man with no traditional VTE risk factors who was diagnosed with a clot in transit three weeks after diagnosis of COVID-19.
Conclusion
UNASSIGNED
Clot in transit is rare but can occur in COVID-19 patients even in the absence of traditional thromboembolism risk factors. Management includes systemic anticoagulation, systemic thrombolysis, and surgical embolectomy. Our patient was successfully treated with systemic thrombolysis.
Identifiants
pubmed: 35811832
doi: 10.1155/2022/3483605
pmc: PMC9259549
doi:
Types de publication
Case Reports
Langues
eng
Pagination
3483605Informations de copyright
Copyright © 2022 Yaman Alali et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
JAMA. 2020 Aug 25;324(8):799-801
pubmed: 32702090
Eur J Heart Fail. 2020 Jun;22(6):1046-1047
pubmed: 32463538
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
CASE (Phila). 2021 Jun;5(3):143-146
pubmed: 33495743
J Thromb Haemost. 2020 Sep;18(9):2358-2363
pubmed: 32633068
Chest. 2020 Sep;158(3):1143-1163
pubmed: 32502594
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
J Intensive Care Med. 2019 Nov-Dec;34(11-12):930-937
pubmed: 30373436
Crit Care Med. 2020 Sep;48(9):e783-e790
pubmed: 32459672
J Am Coll Cardiol. 2003 Jun 18;41(12):2245-51
pubmed: 12821255
J Thromb Haemost. 2020 Jul;18(7):1743-1746
pubmed: 32320517
Eur Radiol. 2020 Nov;30(11):6170-6177
pubmed: 32518989
CASE (Phila). 2020 Aug;4(4):200-203
pubmed: 32426575
Rev Inst Med Trop Sao Paulo. 2020 Sep 04;62:e63
pubmed: 32901760
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
Eur Respir J. 2016 Mar;47(3):869-75
pubmed: 26797032
Chest. 2017 Feb;151(2):409-416
pubmed: 27746202